Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Toxicon ; 93: 51-60, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25454319

RESUMO

The main goal of this work was to develop a strategy to identify B-cell epitopes on four different three finger toxins (3FTX) and one phospholipase A2 (PLA2) from Micrurus corallinus snake venom. 3FTx and PLA2 are highly abundant components in Elapidic venoms and are the major responsibles for the toxicity observed in envenomation by coral snakes. Overlapping peptides from the sequence of each toxin were prepared by SPOT method and three different anti-elapidic sera were used to map the epitopes. After immunogenicity analysis of the spot-reactive peptides by EPITOPIA, a computational method, nine sequences from the five toxins were chemically synthesized and antigenically and immunogenically characterized. All the peptides were used together as immunogens in rabbits, delivered with Freund's adjuvant for a first cycle of immunization and Montanide in the second. A good antibody response against individual synthetic peptides and M. corallinus venom was achieved. Anti-peptide IgGs were also cross-reactive against Micrurus frontalis and Micrurus lemniscatus crude venoms. In addition, anti-peptide IgGs inhibits the lethal and phospholipasic activities of M. corallinus crude venom. Our results provide a rational basis to the identification of neutralizing epitopes on coral snake toxins and show that their corresponding synthetic peptides could improve the generation of immuno-therapeutics. The use of synthetic peptide for immunization is a reasonable approach, since it enables poly-specificity, low risk of toxic effects and large scale production.


Assuntos
Venenos Elapídicos/química , Elapidae , Epitopos de Linfócito B/genética , Fosfolipases A2/genética , Toxinas Biológicas/genética , Sequência de Aminoácidos , Animais , Formação de Anticorpos , Brasil , Técnicas de Química Sintética , Ensaio de Imunoadsorção Enzimática , Imunoglobulina G/metabolismo , Dados de Sequência Molecular , Testes de Neutralização , Peptídeos/genética , Peptídeos/imunologia
2.
Toxicon ; 93: 37-40, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25448393

RESUMO

In this work, an anti-loxoscelic serum was produced by immunizing horses with a recombinant dermonecrotic protein from Loxosceles intermedia (rLiD1). Anti-rLiD1 antibodies were able to recognize different species of Loxosceles venoms by Western Blot and ELISA. The efficacy of anti-rLiD1 serum against the toxic effects of Loxosceles laeta (Peru) venom was tested, showing that anti-rLiD1 serum can neutralize those effects. This study confirms that recombinant proteins can be good candidates to replace crude venoms for antivenom production.


Assuntos
Antivenenos/imunologia , Diester Fosfórico Hidrolases/química , Diester Fosfórico Hidrolases/metabolismo , Proteínas Recombinantes/metabolismo , Venenos de Aranha/química , Animais , Antivenenos/farmacologia , Western Blotting , Brasil , Reações Cruzadas , Ensaio de Imunoadsorção Enzimática , Cavalos , Testes de Neutralização , Peru , Diester Fosfórico Hidrolases/análise , Especificidade da Espécie , Venenos de Aranha/enzimologia
3.
Toxicon ; 70: 90-7, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23648420

RESUMO

This manuscript describes the general biochemical properties and immunological characteristics of Peruvian spider Loxosceles laeta venom (PLlv), which is responsible for the largest number of accidents involving venomous animals in Peru. In this work, we observed that the venom of this spider is more lethal to mice when compared with L. laeta venom from Brazil (BLlv). The LD50 of PLlv was 1.213 mg/kg when the venom was intradermally injected. The venom displayed sphingomyelinase activity and produced dermonecrotic, hemorrhagic and edema effects in rabbits. 2-D SDS-PAGE separation of the soluble venoms resulted in a protein profile ranging from 20 to 205 kDa. Anti-PLlv and anti-BLlv sera produced in rabbits and assayed by ELISA showed that rabbit antibodies cross-reacted with PLlv and BLlv and also with other Brazilian Loxosceles venoms. Western blotting analysis showed that bands corresponding to 25-35 kDa are the proteins best recognized in every Loxosceles spp venoms analyzed. The immunized rabbits displayed protective effect after challenge with PLlv and BLlv. In vitro assays with horse anti-loxoscelic antivenoms produced in Brazil and Peru demonstrated that these commercial antivenoms were efficient to inhibit the sphingomyelinase activity of PLlv and BLlv.


Assuntos
Antivenenos/farmacologia , Diester Fosfórico Hidrolases/toxicidade , Venenos de Aranha/toxicidade , Aranhas/metabolismo , Animais , Western Blotting , Brasil , Reações Cruzadas , Edema/induzido quimicamente , Edema/patologia , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Cavalos , Imunização , Dose Letal Mediana , Masculino , Camundongos , Testes de Neutralização , Peru , Coelhos , Esfingomielina Fosfodiesterase/antagonistas & inibidores , Esfingomielina Fosfodiesterase/metabolismo
4.
Vaccine ; 31(25): 2749-55, 2013 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-23664158

RESUMO

A chimeric protein was constructed expressing three epitopes of LiD1, a dermonecrotic toxin from the venom of Loxosceles intermedia spider. This species is responsible for a large number of accidents involving spiders in Brazil. We demonstrated that the chimeric protein (rCpLi) generated is atoxic and that antibodies previously developed in rabbits against synthetic epitopes reactive with rCpLi in ELISA and immunoblot assays. The antibody response in rabbits against the rCpLi was evaluated by ELISA and we have detected an antibody response in all immunized animals. Overlapping peptides covering the amino acid sequence of the rCpLi were synthesized on a cellulose membrane, and their recognition by rabbit anti-rCpLi serum assessed. Three different antigenic regions were identified. The percentage of inhibition of the dermonecrotic, hemorrhagic and edematogenic activities caused by the recombinant protein LiD1r in naïve rabbits was assessed by pre-incubation with anti-rCpLi antibodies. Anti-rCpLi induced good dermonecrotic and hemorrhagic protection. The levels of protection were similar to the antiboides anti-LiD1r. In summary, we have developed a polyepitope recombinant chimeric protein capable of inducing multiple responses of neutralizing antibodies in a rabbit model. This engineered protein may be a promising candidate for therapeutic serum development or vaccination.


Assuntos
Proteínas Recombinantes de Fusão/química , Venenos de Aranha/química , Animais , Anticorpos Neutralizantes/imunologia , Antivenenos/imunologia , Edema/imunologia , Edema/prevenção & controle , Epitopos de Linfócito B/genética , Hemorragia/imunologia , Hemorragia/prevenção & controle , Necrose/imunologia , Necrose/prevenção & controle , Coelhos , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologia , Pele/imunologia , Pele/patologia , Esfingomielina Fosfodiesterase/química , Esfingomielina Fosfodiesterase/genética , Esfingomielina Fosfodiesterase/imunologia , Venenos de Aranha/genética , Venenos de Aranha/imunologia , Aranhas
5.
Toxicon ; 60(5): 934-42, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22750532

RESUMO

This communication describes the general biochemical properties and some immunological characteristics of the venom from the Peruvian scorpion Hadruroides lunatus, which is the most medically relevant species in Peru. The soluble venom of this scorpion is toxic to mice, the LD50 determined was 0.1 mg/kg and 21.55 mg/kg when the venom was injected intracranial or intraperitoneally, respectively. The soluble venom displayed proteolytic, hyaluronidasic, phospholipasic and cardiotoxic activities. High performance liquid chromatography of the soluble venom resulted in the separation of 20 fractions. Two peptides with phospholipasic activity were isolated to homogeneity and their molecular masses determined by mass spectrometry (MALDI TOF). Anti-H. lunatus venom sera were produced in rabbits. Western blotting analysis showed that most of the protein content of this venom is immunogenic. H. lunatus anti-venom displayed consistent cross-reactivity with venom antigens from the new World-scorpions Tityus serrulatus and Centruroides sculpturatus venoms; however, a weaker reactivity was observed against the venom antigens from the old World-scorpion Androctonus australis Hector.


Assuntos
Venenos de Escorpião/química , Venenos de Escorpião/imunologia , Venenos de Escorpião/intoxicação , Animais , Western Blotting , Fracionamento Químico , Cromatografia Líquida de Alta Pressão , Reações Cruzadas , Ensaio de Imunoadsorção Enzimática , Hialuronoglucosaminidase/metabolismo , Soros Imunes/imunologia , Dose Letal Mediana , Camundongos , Camundongos Endogâmicos C57BL , Peru , Fosfolipases A2/metabolismo , Proteólise , Coelhos , Ratos , Ratos Wistar , Especificidade da Espécie , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
6.
Braz. j. med. biol. res ; 45(3): 216-221, Mar. 2012. ilus, tab
Artigo em Inglês | LILACS | ID: lil-618044

RESUMO

Evaluating the activity of the complement system under conditions of altered thyroid hormone levels might help elucidate the role of complement in triggering autoimmune processes. Here, we investigated alternative pathway (AP) activity in male Wistar rats (180 ± 10 g) after altering their thyroid hormone levels by treatment with triiodothyronine (T3), propylthiouracil (PTU) or thyroidectomy. T3 and thyroxine (T4) levels were determined by chemiluminescence assays. Hemolytic assays were performed to evaluate the lytic activity of the AP. Factor B activity was evaluated using factor B-deficient serum. An anti-human factor B antibody was used to measure factor B levels in serum by radial immunodiffusion. T3 measurements in thyroidectomized animals or animals treated with PTU demonstrated a significant reduction in hormone levels compared to control. The results showed a reduction in AP lytic activity in rats treated with increasing amounts of T3 (1, 10, or 50 µg). Factor B activity was also decreased in the sera of hyperthyroid rats treated with 1 to 50 µg T3. Additionally, treating rats with 25 µg T3 significantly increased factor B levels in their sera (P < 0.01). In contrast, increased factor B concentration and activity (32 percent) were observed in hypothyroid rats. We conclude that alterations in thyroid hormone levels affect the activity of the AP and factor B, which may in turn affect the roles of AP and factor B in antibody production.


Assuntos
Animais , Masculino , Ratos , Antitireóideos/farmacologia , Fator B do Complemento/metabolismo , Via Alternativa do Complemento/efeitos dos fármacos , Propiltiouracila/farmacologia , Tiroxina/sangue , Tri-Iodotironina/sangue , Via Alternativa do Complemento/fisiologia , Hipertireoidismo/sangue , Hipertireoidismo/induzido quimicamente , Hipertireoidismo/imunologia , Hipotireoidismo/sangue , Hipotireoidismo/induzido quimicamente , Hipotireoidismo/imunologia , Medições Luminescentes , Ratos Wistar , Tireoidectomia
7.
Braz J Med Biol Res ; 45(3): 216-21, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22370704

RESUMO

Evaluating the activity of the complement system under conditions of altered thyroid hormone levels might help elucidate the role of complement in triggering autoimmune processes. Here, we investigated alternative pathway (AP) activity in male Wistar rats (180 ± 10 g) after altering their thyroid hormone levels by treatment with triiodothyronine (T3), propylthiouracil (PTU) or thyroidectomy. T3 and thyroxine (T4) levels were determined by chemiluminescence assays. Hemolytic assays were performed to evaluate the lytic activity of the AP. Factor B activity was evaluated using factor B-deficient serum. An anti-human factor B antibody was used to measure factor B levels in serum by radial immunodiffusion. T3 measurements in thyroidectomized animals or animals treated with PTU demonstrated a significant reduction in hormone levels compared to control. The results showed a reduction in AP lytic activity in rats treated with increasing amounts of T3 (1, 10, or 50 µg). Factor B activity was also decreased in the sera of hyperthyroid rats treated with 1 to 50 µg T3. Additionally, treating rats with 25 µg T3 significantly increased factor B levels in their sera (P < 0.01). In contrast, increased factor B concentration and activity (32%) were observed in hypothyroid rats. We conclude that alterations in thyroid hormone levels affect the activity of the AP and factor B, which may in turn affect the roles of AP and factor B in antibody production.


Assuntos
Antitireóideos/farmacologia , Fator B do Complemento/metabolismo , Via Alternativa do Complemento/efeitos dos fármacos , Propiltiouracila/farmacologia , Tiroxina/sangue , Tri-Iodotironina/sangue , Animais , Via Alternativa do Complemento/fisiologia , Hipertireoidismo/sangue , Hipertireoidismo/induzido quimicamente , Hipertireoidismo/imunologia , Hipotireoidismo/sangue , Hipotireoidismo/induzido quimicamente , Hipotireoidismo/imunologia , Medições Luminescentes , Masculino , Ratos , Ratos Wistar , Tireoidectomia
8.
Int Immunopharmacol ; 3(10-11): 1419-27, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12946438

RESUMO

Propylthiouracil (PTU) was employed in a fixed quantity to evaluate the effect of the period of treatment with this drug on the antibody response to sheep red blood cells in Wistar rats. Animals were treated for 8, 16, 30 and 90 days by intragastric route with 5 mg/day, and immunized 24 h following the end of treatment; other groups were treated for 21 days, and immunized on the 17th day of treatment. Animals were sacrificed 5 or 6 days following immunization; the primary response was evaluated by the number of plaque-forming spleen cells and in some cases also by enzyme-linked immunosorbent assay (ELISA). Secondary response of PTU-treated rats, immunized and boostered after 15 days, was evaluated by ELISA 3 days following the booster. RIA performed the measurement of T3 in animals treated for 16 days, immunized, and sacrificed after 1, 2, 3, 4 and 5 days following immunization. Results showed that treatment for 8 and 16 days increased production of antibodies, and for 30 and 90 days decreased this response. Thus, according to the period of treatment, the same dose of PTU stimulates or suppresses the antibody response. This biphasic effect of a single dose of PTU was independent of alterations of serum levels of T3 during the buildup of the immune response. These results contributes towards the understanding of the literature controversy regarding the effects of this drug on the immune response, and could be of interest for studies involving autoimmune processes in thyroid.


Assuntos
Formação de Anticorpos/efeitos dos fármacos , Antitireóideos/farmacologia , Propiltiouracila/farmacologia , Administração Oral , Animais , Antitireóideos/administração & dosagem , Ensaio de Imunoadsorção Enzimática , Técnica de Placa Hemolítica , Imunização , Masculino , Propiltiouracila/administração & dosagem , Ratos , Ratos Wistar , Baço/imunologia , Fatores de Tempo , Tri-Iodotironina/sangue
9.
Invest Radiol ; 36(1): 56-63, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11176262

RESUMO

RATIONALE AND OBJECTIVES: There is a need for practical and sensitive preclinical tests for detecting the kidney toxicity of chemicals. The spontaneously hypertensive rat (SHR), as it ages, develops renal and cardiovascular changes similar to those considered as human risk factors for radiocontrast-induced renal damage. Age, male gender, and uncontrolled hypertension make these animals susceptible to the volume and osmolality of the administered contrast agent and the effect of repeated contrast administration after a brief interval. This article reviews studies in which the role of these and other factors were evaluated to validate the male SHR as a small animal model for renal damage induced by contrast and other agents. METHODS: Systolic blood pressure was measured with a tail cuff before and after the administration of the experimental substances, and the left kidney and heart were studied histologically to determine the influence of age, dose of contrast repeated at a short interval, gender and strain, the role of the sympathetic adrenergic nervous system, osmolality, and apoptosis. RESULTS: As the animals aged and the systolic blood pressure remained elevated, the animals developed progressive renal lesions that worsened after the administration of contrast. The most advanced renal lesions occurred in adult male SHRs that received two doses of contrast 6 hours apart. Female SHR rats and male Wistar Kyoto rats showed no effect or only minimal changes in heart and kidneys after the administration of contrast compared with age-matched male SHRs. Adrenergic blockade allowed only a small elevation in systolic blood pressure after contrast administration but did not protect the kidneys against renal damage by contrast. Hypaque, Omnipaque, and mannitol caused renal damage in proportion to their osmolality. Apoptosis with Hypaque, Omnipaque, and mannitol was observed in the kidney and heart. CONCLUSION: The results indicate that the aging male SHR develops spontaneous renal lesions that progress with age, increasing the susceptibility to the renal-damaging effects of contrast. Thus, the aging male SHR provides a laboratory tool for detecting the risk of renal damage of new contrast media as well as other pharmaceuticals and assessing methods to protect the kidneys and possible mechanisms of renal damage.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/etiologia , Meios de Contraste/efeitos adversos , Diatrizoato de Meglumina/efeitos adversos , Iohexol/efeitos adversos , Fatores Etários , Envelhecimento , Animais , Apoptose/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Creatinina/sangue , Feminino , Masculino , Concentração Osmolar , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Fatores Sexuais
11.
Int J Immunopharmacol ; 22(1): 25-33, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10684986

RESUMO

The effect of propylthiouracil (PTU) on the lytic activity of complement in rat serum was investigated in vivo. Rats (180+/-10 g) were treated daily by gavage with PTU doses of 1-50 mg/200 g body weight for time intervals ranging from 1 to 30 days. Serum classical pathway (CP) and alternative pathway (AP) activities were determined 24 h after the last dose. A single dose of 50 mg/200 g body weight was administered to additional groups and the animals were sacrificed after periods of 1-48 h. The results showed a relatively small reduction ( approximately 30%) in CP activity, evident only in animals treated with 50 mg of PTU for three weeks. However, a clear and opposite effect of PTU, an increase in lytic activity reaching values up to 180% of controls, was observed on AP activity. This effect was seen at all PTU doses used, and occurred within 4 days of treatment with the highest dose. Maximum activity was observed at intermediate intervals, depending on the PTU dose, with a return to control levels occurring after the longer periods of treatment. The lytic activity of serum from animals treated with a single PTU dose of 50 mg/200 g body weight and sacrificed 1-48 h after dosing did not differ from controls. Serum levels of thyroid hormone (triiodo L-thyronine, T3, and thyroxine, T4) were determined in representative groups of treated animals (injected with 5 mg of PTU/200 g body weight/day). These were either undetectable or considerably lower than those of controls. The serum PTU levels of these rats increased for up to 22 days, reaching values of 2-4 microg/ml.PTU is described in the literature as a modulator of both cellular immune responses and antibody production. Upon complement activation fragments of complement components bind to immune complexes and to specific receptors on cells of the immune system. Thus, alteration in AP activity caused by PTU treatment suggests a possible mechanism by which the drug exerts its modulatory effect. Increased complement AP activity might affect events as antigen presentation and hence the onset and course of the immune response.


Assuntos
Antitireóideos/farmacologia , Via Alternativa do Complemento/efeitos dos fármacos , Propiltiouracila/farmacologia , Animais , Masculino , Propiltiouracila/sangue , Ratos , Ratos Wistar , Hormônios Tireóideos/sangue
12.
Immunol Invest ; 28(5-6): 311-21, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10574629

RESUMO

This work investigated the correlation between serum levels of factor B, AP-lytic activity, ratio of factor B activation by zymosan, and AP-dependent neutrophil phagocytosis in samples of normal human serum (NHS). In addition, since the antithyroid drug propylthiouracil (PTU) induces increased levels of AP lytic activity in rats, groups of these animals were treated with this drug in order to increase AP titers and to evaluate those parameters also in this condition. The results showed no correlation between factor B concentration and AP lytic activity in 18 samples of NHS or between factor B concentration and proportion of consumption by zymosan. Interestingly, this consumption was also not correlated with phagocytosis as measured by the chemiluminescence (CL) response of neutrophils to the opsonized particles. The two biological properties of phagocytosis and lytic activity, dependent of AP, were not correlated to each other in the NHS samples. In the samples of rat serum with increased AP lytic levels a different result was observed. A positive correlation between CL response and lytic activity occurred in serum of animals receiving a low PTU dose, but not in serum of animals receiving a high dose, where CL responses were lower than those of controls. The results are compared to literature data and discussed in terms of individual differences in resistance or susceptibility to infections and or diseases involving the complement system.


Assuntos
Fator B do Complemento/metabolismo , Via Alternativa do Complemento/imunologia , Hemólise/imunologia , Neutrófilos/imunologia , Fagocitose/imunologia , Animais , Antitireóideos/farmacologia , Via Alternativa do Complemento/efeitos dos fármacos , Relação Dose-Resposta Imunológica , Eritrócitos/imunologia , Feminino , Hemólise/efeitos dos fármacos , Humanos , Medições Luminescentes , Neutrófilos/efeitos dos fármacos , Proteínas Opsonizantes/imunologia , Fagocitose/efeitos dos fármacos , Propiltiouracila/farmacologia , Coelhos , Ratos , Zimosan/farmacologia
13.
Toxicol Pathol ; 27(4): 427-35, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10485823

RESUMO

The induction of apoptosis by contrast media (CM) and mannitol (M) was investigated in the hearts and kidneys of 12-mo-old male SHR rats. Ten groups of 3 SHR rats received a dose of 5 ml/kg of one of the following: Hypaque (H)-30, H-60, H-76, Omnipaque (O)-140, O-350, mannitol (M)-4%, M-9%, M-19%, M-27%, or saline (S). DNA fragmentation was detected using the terminal deoxynucleotidyl transferase-mediated [TdT] dUTP nick-end labeling (TUNEL) method, and the morphology characteristics of apoptosis were confirmed in cardiac and renal cells. The immunoreactivities of Bcl-2, Bax, and p53 were assessed immunohistochemically in the kidneys. Apoptosis occurred in cardiac myocytes and renal tubular and glomerular cells as well as in vascular endothelial and smooth muscle cells of the heart and kidneys. The high frequency of apoptosis correlated significantly with the increase in the osmolality of the H, O, and M. The increased Bax, the increased p53, and the decreased Bcl-2 immunoreactivities were detected in H- or O-treated, but not in M-treated, rats. These findings suggest that CM and M activate cardiac and renal apoptosis by different mechanisms and that the apoptotic process may be implicated in acute heart and renal damage.


Assuntos
Apoptose/efeitos dos fármacos , Meios de Contraste/toxicidade , Coração/efeitos dos fármacos , Rim/efeitos dos fármacos , Manitol/toxicidade , Animais , Imuno-Histoquímica , Rim/química , Rim/patologia , Masculino , Miocárdio/química , Miocárdio/patologia , Concentração Osmolar , Proteínas Proto-Oncogênicas/análise , Proteínas Proto-Oncogênicas c-bcl-2/análise , Ratos , Ratos Endogâmicos SHR , Índice de Gravidade de Doença , Proteína Supressora de Tumor p53/análise , Desmame , Proteína X Associada a bcl-2
14.
Invest Radiol ; 34(7): 455-62, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10399635

RESUMO

RATIONALE AND OBJECTIVES: The purpose of this research was to study the effects of the radiocontrast medium (CM) Hypaque-76 (diatrizoate meglumine sodium), equiosmolar mannitol, and endothelin on blood pressure and renal damage in a aging male spontaneously hypertensive rat, a small animal model for CM-induced renal damage. The importance of the pressor effect and the high osmolality of CM in producing renal damage was investigated by first reducing the blood pressure with pentobarbital anesthesia, which suppresses sympathetic nervous system activity, then testing the effects of CM, saline, mannitol, and the potent vasoconstrictor endothelin alone and in combination with CM. METHODS: Systolic blood pressure was measured in 14-month-old male rats (1) when awake, (2) after pentobarbital anesthesia, (3) after the administration of saline, CM, mannitol, endothelin, or CM plus endothelin, (4) after awakening the same day, and (5) the following day while awake. Renal damage was quantified by evaluating histopathologically the left kidney removed the day after administration of test substances. RESULTS: The pentobarbital-lowered blood pressure remained depressed after saline and mannitol but rose dramatically after CM, endothelin, and CM plus endothelin. Renal damage, compared with the saline controls, occurred with CM, mannitol, endothelin, and endothelin plus CM. The order of increasing severity was mannitol = CM < endothelin < endothelin plus CM. CONCLUSIONS: The effect of CM on systolic blood pressure is not related to its osmolality. High osmolality, however, appears to be a factor in CM-induced renal damage. Ischemia and direct nephrotoxicity are factors contributing to the renal-damaging effects of CM, mannitol, and endothelin.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Meios de Contraste/toxicidade , Diatrizoato de Meglumina/toxicidade , Diatrizoato/toxicidade , Diuréticos Osmóticos/toxicidade , Endotelinas/toxicidade , Nefropatias/induzido quimicamente , Manitol/toxicidade , Envelhecimento/efeitos dos fármacos , Animais , Combinação de Medicamentos , Hipertensão/fisiopatologia , Nefropatias/patologia , Masculino , Ratos , Ratos Endogâmicos SHR
15.
Invest Radiol ; 33(2): 104-12, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9493726

RESUMO

RATIONALE AND OBJECTIVES: The systemic administration of hypertonic solutions may activate the adrenergic system, thus triggering vasomotor reactions that may result in renal failure. In this study, the effects of diatrizoate meglumine sodium radiocontrast agent Hypaque-76 on systolic blood pressure (BP) and renal damage were determined in male spontaneously hypertensive (SH) rats and Wistar Kyoto (WKY) rats under adrenergic blockade. METHODS: The systolic BP was measured in ketamine-anesthetized male SH and WKY rats after administration of saline solution, radiocontrast, or endothelin during adrenergic blockade with phentolamine. Then the left kidney was removed and examined histologically. RESULTS: The fall in systolic BP after phentolamine was not influenced by saline solution or radiocontrast in WKY rats but was restored partially by radiocontrast in SH rats. Endothelin produced an elevation in BP toward baseline levels in both strains. Only moderate renal damage was observed in the kidneys of WKY rats given radiocontrast or endothelin, but very severe damage was produced by these agents in SH rats. CONCLUSIONS: Adrenergic blockade with phentolamine did not prevent the elevation in systolic BP in SH rats by radiocontrast or by endothelin in SH and WKY rats, nor did it protect against renal damage by radiocontrast or by endothelin in SH rats.


Assuntos
Antagonistas Adrenérgicos alfa/farmacologia , Pressão Sanguínea/efeitos dos fármacos , Meios de Contraste/administração & dosagem , Diatrizoato de Meglumina/administração & dosagem , Diatrizoato/administração & dosagem , Endotelinas/administração & dosagem , Hipertensão/complicações , Rim/efeitos dos fármacos , Fentolamina/farmacologia , Animais , Modelos Animais de Doenças , Combinação de Medicamentos , Rim/inervação , Masculino , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Sistema Nervoso Simpático/efeitos dos fármacos
16.
Ren Fail ; 19(6): 723-43, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9415930

RESUMO

The male spontaneously hypertensive rat (SHR), as it ages, suffers many of the renal and cardiovascular complications that are recognized in humans as risk factors for radiocontrast (RC) agent induced renal failure (RF). Knowledge of this led us to test this strain of rats as a small animal model for RC-induced renal failure (RC-RF). Functional studies demonstrated a significant fall in GFR in the recovery period after RC administration. In addition, histopathologic evaluation of the kidneys was done in this study. Our results are based on assigning separate scale values to the histopathological evaluation of the (a) glomeruli, (b) tubules, (c) interstitium, and (d) arteries and arterioles of the kidneys. Saline (S) was administered to one group and the RC agent Hypaque-76 (diatrizoate meglumine sodium) to paired groups of 5-, 8-, 10-, 12-, and 14-month-old male SHR. The results indicated that younger animals (5 and 8 months old) were resistant to the nephrotoxic effects of the RC, but developed susceptibility at 10 months of age, when spontaneous renal pathology became manifest. Both spontaneous renal pathology and RC-induced renal damage (RC-RD) increased as the animals aged. In addition, when the administered dose of RC was repeated after a short interval of only 6 h, the degree of RC-RD increased greatly. In parallel control studies of the influence of gender and strain on the response to RC in 12-month-old rats, neither hypertensive female SHR nor male normotensive Wistar-Kyoto (WKY) rats demonstrated significant spontaneous renal pathology or the marked susceptibility to RC nephrotoxicity shown by their male SHR counterparts. This small animal model for RC-RD, the mature male SHR, has the distinct advantage that risk factors for RC-RD, similar to those characterized in humans for RC-RF, develop spontaneously without requiring any special treatment or surgical intervention.


Assuntos
Meios de Contraste/efeitos adversos , Diatrizoato de Meglumina/efeitos adversos , Diatrizoato/efeitos adversos , Insuficiência Renal/induzido quimicamente , Fatores Etários , Animais , Meios de Contraste/administração & dosagem , Diatrizoato/administração & dosagem , Diatrizoato de Meglumina/administração & dosagem , Modelos Animais de Doenças , Combinação de Medicamentos , Feminino , Taxa de Filtração Glomerular , Glomérulos Renais/patologia , Túbulos Renais/patologia , Masculino , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Artéria Renal/patologia , Insuficiência Renal/patologia , Fatores de Risco , Fatores Sexuais , Especificidade da Espécie
17.
Clin Lab Med ; 13(1): 33-52, 1993 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8462268

RESUMO

The tests most commonly used to estimate the status of renal function via alterations in glomerular filtration rate (GFR) are plasma creatinine concentration (PCr), blood, urea, nitrogen (BUN), and creatinine clearance (CCr). Unfortunately, these tests have some drawbacks. Nevertheless, they are quite useful to clinicians aware of their limitations, especially in many instances when it may be unnecessary or impractical to have precise measurements. Accordingly, serial measurements of PCr, especially when related to simultaneous BUN determinations, or CCr, may suffice. However, the functional status of the kidneys often needs to be corroborated by more precise methods when subtle changes in renal function are detected or when clinically indicated.


Assuntos
Nefropatias/fisiopatologia , Glomérulos Renais/fisiopatologia , Túbulos Renais/fisiopatologia , Rim/fisiopatologia , Animais , Taxa de Filtração Glomerular , Testes de Função Renal , Circulação Renal
19.
Magnesium ; 3(2): 95-106, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6503360

RESUMO

Metabolic balance studies were performed in two groups of 6 rats each, pair-fed a diet deficient in potassium. While one group was injected with desoxycorticosterone acetate (DOCA) for 11 days, the other group, used as a control, was injected with oil. The administration of DOCA suppressed or reversed the thirst, natriuresis, diuresis, calciuria and magnesiuria that developed in the potassium-deficient control group. Potassium-depleted DOCA-treated rats had a more positive water and sodium balance, experienced a significant expansion in plasma volume, had a more negative potassium balance and had a lower plasma potassium concentration. Magnesium balance decreased in the group fed the diet deficient in potassium and injected with oil but it rose towards control levels in the group fed the same diet and treated with DOCA. As the content of potassium in muscle decreased in rats fed the diet deficient in potassium and injected with oil, the concentration of magnesium in muscle also fell and the plasma concentration of magnesium increased. Thus, the hypermagnesemia of potassium depletion could be explained by the shifting of magnesium from tissue into the extracellular space. The partial compensation of the hypermagnesemia observed in the potassium-deficient group injected with DOCA may be the result of the hemodilution secondary to plasma expansion.


Assuntos
Desoxicorticosterona/farmacologia , Magnésio/metabolismo , Deficiência de Potássio/metabolismo , Animais , Cálcio/metabolismo , Diurese/efeitos dos fármacos , Fezes/metabolismo , Magnésio/sangue , Magnésio/urina , Masculino , Natriurese/efeitos dos fármacos , Deficiência de Potássio/sangue , Ratos , Ratos Endogâmicos
20.
Am J Physiol ; 234(6): F466-71, 1978 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-665773

RESUMO

In rats, a diet depleted of potassium caused a significant hypokalemia and hypermagnesemia, a diuresis and natriuresis, a decrease in urinary and fecal excretion of potassium, a magnesiuria, and a decrease in fecal excretion of magnesium. Balance studies revealed that potassium metabolism was negative in potassium-depleted rats and that magnesium metabolism was positive and higher than in control rats. In potassium-depleted rats, potassium and magnesium contents in muscle were reduced, whereas the sodium level was increased and plasma aldosterone was significantly lower. Therefore, the elevation in plasma concentration of magnesium induced by a diet poor in potassium is the result of a more positive metabolic balance of magnesium and of shifting of magnesium from the tissue into the plasma compartment. Results of additional preliminary studies support the possibility that the hypermagnesemia may be mediated through the depression in mineralocorticoid activity induced by the depletion of potassium.


Assuntos
Magnésio/metabolismo , Deficiência de Potássio/metabolismo , Animais , Magnésio/sangue , Masculino , Músculos/metabolismo , Potássio/metabolismo , Deficiência de Potássio/sangue , Deficiência de Potássio/urina , Ratos , Sódio/metabolismo , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...